906
L.-K. Sy, G. D. Brown / Tetrahedron 58 #2002) 897±908
Compound 12:31 oil. -2.1 mg, 6%; Rt 10.2 min, 50%
EtOAc/n-hexane; Rt 35.1 min, 15% EtOAc/n-hexane). IR
s), 1.18 -3H, d, J6.9 Hz), 0.94 -3H, d, J6.4 Hz)Ðsee
also Table 2; 13C NMR: see Table 1; HREIMS m/z -rel.
int.) 250.1570 [M12H2O, C15H22O3 requires 250.1569]
-22), 232 -23), 222 -7), 192 -16), 167 -36), 149 -100);
CIMS: 269 [M11] -35), 251 -28), 233 -100), 205 -52).
nmax -CHCl3): 3026, 2934, 2874, 1751, 1456 cm21 1H
;
NMR d -CDCl3) ppm: 5.53 -1H, s), 2.74 -1H, dq, J9.0,
8.0 Hz), 2.19 -1H, ddd, J12.5, 9.0, 2.5 Hz), 1.70 -3H, s),
1.35 -3H, d, J8.0 Hz), 0.96-3H, d, J6.2 Hz)Ðsee also
Table 2; 13C NMR: see Table 1; HREIMS m/z -rel. int.)
234.1613 [M1, C15H22O2 requires 234.1620] -19), 219 -4),
190 -91), 161 -100).
Compound 19: oil. -2.3 mg, 8%; Rt 16.6 min, 50%
EtOAc/n-hexane; Rt 60.0 min, 22% EtOAc/n-hexane); H
1
NMR d -CDCl3) ppm: 6.08 -1H, s), 2.95 -1H, dq, J7.2,
7.0 Hz), 2.63 -1H, ddd, J17.8, 9.2, 4.8 Hz), 2.45 -1H, ddd,
J17.8, 8.5, 8.5 Hz), 2.16-3H, s), 1.22 -3H, d, J7.0 Hz),
0.99 -3H, d, J6.1 Hz)Ðsee also Table 2; 13C NMR: see
Table 1; HREIMS m/z -rel. int.) 250.1575 [M1, C15H22O3
requires 250.1569] -3), 232 -3), 211 -1), 192 -100).
Compound 13:4 oil. -0.9 mg, 3%; Rt 11.5 min, 50%
EtOAc/n-hexane; Rt 21.0 min, 15% EtOAc/n-hexane); H
1
NMR d -CDCl3) ppm: 6.13 -1H, s, H-5), 3.84 -1H, q,
J6.9 Hz, H-11), 1.79 -3H, s, H-15), 1.23 -3H, d,
J6.9 Hz, H-13), 0.99 -3H, d, J6.0 Hz, H-14); HREIMS
m/z -rel. int.) 234.1614 [M1, C15H22O2 requires 234.1620]
-44), 189 -30), 161 -100).
Compound 20: oil. -1.0 mg, 3%; Rt 42.3 min, 50%
EtOAc/n-hexane; Rt 42.5 min, 15% EtOAc/n-hexane). IR
nmax -CHCl3): 3400±2600 -br), 2930, 2856, 1740,
Compound 14:3,35 oil. -2.4 mg, 8%; Rt 18.0 min, 50%
EtOAc/n-hexane; Rt 28.8 min, 15% EtOAc/n-hexane); H
1715 cm21; H NMR d -CDCl3) ppm: 6.19 -1H, s), 5.92
1
1
-1H, d, J13.2 Hz, 50-OH), 5.69 -1H, d, J13.2 Hz), 2.18
-3H, s), 2.07 -3H, s), 1.15 -3H, d, J6.9 Hz), 1.12 -3H, d,
J7.2 Hz), 1.07 -3H, d, J6.3 Hz), 0.86 -3H, d,
J7.1 Hz)Ðsee also Table 2; 13C NMR: see Table 1;
CIMS: m/z -rel. int.) 515 [M11] -62), 281 -100).
NMR d -CDCl3) ppm: 3.02 -1H, s, H-5), 2.77 -1H, dq,
J7.5, 7.8 Hz, H-11), 2.25 -1H, ddd, J13.4, 7.5, 2.9 Hz,
H-7), 1.38 -3H, d, J7.8 Hz, H-13), 1.36-3H, s, H-15), 0.96
-3H, d, J6.6 Hz, H-14); 13C NMR: 179.5 -C, C-12), 82.9
-C, C-6), 59.5 -CH, C-5), 58.1 -C, C-4), 50.2 -CH, C-7),
45.6-CH, C-1), 38.6-CH, C-11), 34.8 -CH 2, C-9), 30.5
-CH, C-10), 24.1 -CH2, C-3), 23.1 -CH3, C-15), 21.6
-CH2, C-8), 18.6-CH , C-14), 16.3 -CH2, C-2), 12.6-CH ,
Compound 21:28,41 oil. -1.4 mg, 4%; Rt 10.8 min, 50%
EtOAc/n-hexane; Rt 12.3 min, 30% EtOAc/n-hexane); H
1
NMR d -CDCl3) ppm: 5.70 -1H, s), 3.18 -1H, dq, J12.1,
7.2 Hz), 2.00 -1H, ddd, J12.1, 4.4, 4.4 Hz), 1.53 -3H, s),
1.20 -3H, d, J7.2 Hz), 0.94 -3H, d, J5.6Hz)Ðsee also
Table 2; 13C NMR: see Table 1; HREIMS m/z -rel. int.)
266.1517 [M1, C15H22O4 requires 266.1518] -7), 224 -28),
195 -18), 165 -100), 151 -60).
3
3
C-13).
Compound 15: oil. -0.9 mg, 3%; Rt 9.2 min, 50% EtOAc/n-
hexane; Rt 13.1 min, 15% EtOAc/n-hexane). IR nmax
-CHCl3) 3013, 2927, 2854, 1759 cm21
;
1H NMR d
-CDCl3) ppm: 5.79 -1H, s), 2.63 -1H, dq, J8.4, 7.7 Hz),
2.35 -1H, m), 2.12 -1H, ddd, J12.8, 8.4, 3.4 Hz), 2.05 -1H,
m), 1.60 -3H, s), 1.32 -3H, d, J7.7 Hz), 0.94 -3H, d,
J6.6 Hz)Ðsee also Table 2; 13C NMR: see Table 1;
HREIMS m/z -rel. int.) 250.1571 [M1, C15H22O3 requires
250.1569] -11), 222 -8), 192 -2), 179 -100), 151 -26); CIMS:
251 [M11] -100), 233 -34), 223 -11), 205 -35).
4.5. Ozonolysis of dihydroartemisinic acid 2
A cooled -2788) solution of dihydroartemisinic acid -2)
-57 mg, 0.24 mmol) in CH2Cl2/CH3OH -1:1, 40 ml) was
subjected to ozonolysis to give an oil -52 mg, 90% w/w),
which was separated by HPLC -35% EtOAc/n-hexane).
Compound 16: oil. -1.8 mg, 6%; Rt 14.2 min, 50%
EtOAc/n-hexane; Rt 22.0 min, 15% EtOAc/n-hexane); H
Compound 22: oil. -20 mg, 0.07 mmol, 31%; Rt 31.0 min).
[a]D246.7 -c 0.57, CHCl3); IR nmax -CHCl3): 3400±2600
-br), 2936, 2855, 1706 cm21; 1H NMR d -CDCl3) ppm: 9.97
-1H, br s), 2.67 -2H, br s), 2.15 -3H, s), 1.23 -3H, d,
J7.0 Hz), 0.98 -3H, d, J6.3 Hz)Ðsee also Table 2; 13C
NMR: see Table 1; HREIMS m/z -rel. int.) 250.1574
[M12H2O, C15H22O3 requires 250.1569] -3), 227 -31),
209 -100), 181 -100).
1
NMR d -CDCl3) ppm: 6.07 -1H, s), 4.91 -1H, dd, J6.8,
6.8 Hz), 2.58 -2H, m), 1.77 -3H, s), 1.26 -3H, d, J6.8 Hz),
0.87 -3H, d, J6.4 Hz)Ðsee also Table 2; 13C NMR: see
Table 1; HREIMS m/z -rel. int.) 250.1569 [M1, C15H22O3
requires 250.1569] -35), 232 -4), 177 -100), 159 -58), 133
-70).
Compound 23: oil. -5 mg, 0.02 mmol, 7%; Rt 23.5 min); 1H
NMR d -CDCl3) ppm: 5.02 -1H, d, J6.4 Hz), 3.46 -3H, s),
2.75 -1H, ddd, J16.9, 9.6, 3.8 Hz), 2.61 -1H, dq, J3.8,
7.1 Hz), 2.33 -1H, ddd, J16.9, 8.0, 5.2 Hz), 2.14 -3H, s),
1.21 -3H, d, J7.1 Hz), 0.97 -3H, d, J6.4 Hz)Ðsee also
Table 2; 13C NMR: see Table 1.
Compound 17: oil. -1.0 mg, 3%; Rt 11.1 min, 50%
EtOAc/n-hexane; Rt 17.3 min, 15% EtOAc/n-hexane). The
sample decomposed to 21 after puri®cation under laboratory
conditions within a few days. 1H NMR d -CDCl3) ppm: 5.88
-1H, s), 5.47 -1H, s), 2.74 -1H, m), 2.67±2.64 -2H, m), 2.58
-1H, dq, J4.4, 7.1 Hz), 1.43 -3H, s), 1.30 -3H, s), 1.23 -3H,
d, J7.1 Hz), 1.19 -3H, d, J7.0 Hz), 0.92 -3H, d,
J6.4 Hz), 0.89 -3H, d, J7.0 Hz)Ðsee also Table 2; 13C
NMR: see Table 1; CIMS: 477 -100), 281 -52).
4.6. Conversion of a CDCl3 solution of 3 into enol lactone
19 by treatment with TFA under an atmosphere of
nitrogen
Compound 18: oil. -9.1 mg, 30%; Rt 30.8 min, 50%
EtOAc/n-hexane; Rt 68.0 min, 30% EtOAc/n-hexane); H
NMR d -CDCl3) ppm: 9.58 -1H, d, J4.9 Hz), 2.14 -3H,
1
Dissolved oxygen was removed from a solution of 3
-10 mg) in CDCl3 -0.6ml) as earlier and TFA -2 ml) was